Inflammatory diseases: Function of LncRNAs in their emergence and the role of mesenchymal stem cell secretome in their treatment

Pathol Res Pract. 2023 Sep:249:154758. doi: 10.1016/j.prp.2023.154758. Epub 2023 Aug 9.

Abstract

One of the best treatments for inflammatory diseases such as COVID-19, respiratory diseases and brain diseases is treatment with stem cells. Here we investigate the effect of stem cell therapy in the treatment of brain diseases.Preclinical studies have shown promising results, including improved functional recovery and tissue repair in animal models of neurodegenerative diseases, strokes,and traumatic brain injuries. However,ethical implications, safety concerns, and regulatory frameworks necessitate thorough evaluation before transitioning to clinical applications. Additionally, the complex nature of the brain and its intricate cellular environment present unique obstacles that must be overcome to ensure the successful integration and functionality of genetically engineered MSCs. The careful navigation of this path will determine whether the application of genetically engineered MSCs in brain tissue regeneration ultimately lives up to the hype surrounding it.

Keywords: MSCs; Neurological disorders; Regenerative medicine; Stem cell transplantation.

Publication types

  • Review

MeSH terms

  • Animals
  • COVID-19*
  • Mesenchymal Stem Cells*
  • RNA, Long Noncoding*
  • Secretome
  • Stroke*

Substances

  • RNA, Long Noncoding